Lung Cancer News

A commonly asked questions sheet addressing needs related to comprehension of lung cancer screening results was positively received by patients and clinicians, according to study results published in CHEST.

A prediction model that incorporates both exhaled breath data from an electronic nose and basic demographics was able to identify lung cancer in a cohort of patients, according to study results published in CHEST.

Primary endpoints of randomized clinical trials for cancer therapies frequently change after trial initiation, according to findings published in JAMA Network Open.

First-line osimertinib plus chemotherapy extended PFS compared with osimertinib alone for patients with locally advanced or metastatic EGFR-mutated non-small cell lung cancer, topline results of the randomized phase 3 FLAURA2 trial showed.

Certain clinical and socioeconomic factors appeared to predict delays in time to treatment initiation among patients with various cancer types, according to study results published in JCO Oncology Practice.

During the time that nurse educator Lauren McGovern, MSN, RN, OCN, researched ways to gamify oncology infusion nursing orientation, she also happened to be looking for an escape room to entertain her kids.

Deaths with cancer as either an underlying or primary cause decreased across the United States during the first year of the COVID-19 pandemic when compared with the previous year, according to data published in JCO Oncology Practice.

Lung nodule evaluations are crucial when working proactively against lung cancer, but some patients face disparities in managing them, according to a research statement published in American Journal of Respiratory and Critical Care.

Cancer death rates decreased overall across congressional districts in the United States over the past 25 years, according to a study published in Cancer.

In this edition, tumor mutational burden linked to immunotherapy response; toripalimab regimen extends EFS in stage III NSCLC; phase 3 study designed for increasing trial diversity, and more.